← All companies

PSTV

Plus Therapeutics, Inc.

PSTV Nasdaq Surgical & Medical Instruments & Apparatus EDGAR ↗

$3.87

+0.00 0.00%

Key statistics

from XBRL data in SEC filings

Market cap

$26.6M

Revenue (TTM)

$5.18M

Net income (TTM)

-$11.9M

EPS (TTM)

$28.52

P/E ratio

0.1

Dividend yield

—

Free cash flow

-$20.8M

Cash

$3.02M

Total assets

$19.9M

Gross margin

8.5%

52-week range

$2.90 – $23.43

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Entered a material agreement Jun 5, 2026 8-K Shareholder vote results May 15, 2026 10-Q Quarter ended 2026-03-31 May 15, 2026 8-K Results of operations (earnings release) May 15, 2026 8-K Other events Apr 21, 2026 8-K Director or officer change Apr 9, 2026 8-K Other events Apr 8, 2026 8-K Modified rights of security holders; Amended charter or bylaws; Other events Apr 2, 2026 8-K Director or officer change Mar 26, 2026 8-K Item 5.08; Other events Mar 12, 2026 10-K Fiscal year ended 2025-12-31 Mar 12, 2026 8-K Results of operations (earnings release) Mar 12, 2026 8-K Director or officer change Feb 13, 2026 8-K Other events Jan 22, 2026 8-K Entered a material agreement; Other events Jan 16, 2026 8-K Regulation FD disclosure; Other events Nov 17, 2025 10-Q Quarter ended 2025-09-30 Oct 30, 2025 8-K Results of operations (earnings release) Oct 30, 2025 8-K Entered a material agreement; Took on a direct financial obligation Oct 21, 2025 8-K Other events Aug 26, 2025 8-K Other events Aug 14, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Results of operations (earnings release) Aug 14, 2025 8-K Other events Aug 13, 2025 8-K Shareholder vote results Aug 12, 2025 8-K Changed accountants Jul 18, 2025 8-K Entered a material agreement; Unregistered sale of equity Jun 20, 2025 8-K Entered a material agreement; Modified rights of security holders Jun 17, 2025 8-K Delisting notice or listing-rule failure Jun 6, 2025 8-K Results of operations (earnings release) May 30, 2025 10-Q Quarter ended 2025-03-31 May 30, 2025 8-K Delisting notice or listing-rule failure; Regulation FD disclosure May 23, 2025 8-K Delisting notice or listing-rule failure May 19, 2025 8-K Amended charter or bylaws; Shareholder vote results; Other events May 2, 2025 10-K/A Fiscal year ended 2024-12-31 Apr 30, 2025 8-K Director or officer change Apr 18, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K Results of operations (earnings release) Mar 27, 2025 8-K Other events Mar 10, 2025 8-K Entered a material agreement; Unregistered sale of equity Mar 4, 2025